Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,068) with videos related to
Page
of 107
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2017
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3
Yong-Chen Lu, Linda L Parker, Tangying Lu, et al.
Cancer Research Communications
|
July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Nature Communications
|
October 6, 2024
GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency
Justin A Guerrero, Dorota D Klysz, Yiyun Chen, et al.
Blood
|
December 14, 2011
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N Kochenderfer, Mark E Dudley, Steven A Feldman, et al.
JCI Insight
|
December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
Christopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2017
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
Yasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, et al.
Blood Cancer Discovery
|
December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Hrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Seminars in Vascular Surgery
|
November 22, 2022
The art of peer review: Guidelines to become a credible and constructive peer reviewer
M Libby Weaver, Rachael Sundland, Alexandra M Adams, et al.
The Oncologist
|
December 21, 2018
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis
Steven M Bair, Lauren E Strelec, Tatyana A Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma
Ling Zhang, Richard A Morgan, Joal D Beane, et al.
Page
of 107
Search research articles
Search
Showing results (1001-1010 of 1,068) with videos related to
Sort By:
Page
of 107
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2017
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3
Yong-Chen Lu, Linda L Parker, Tangying Lu, et al.
Cancer Research Communications
|
July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Nature Communications
|
October 6, 2024
GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency
Justin A Guerrero, Dorota D Klysz, Yiyun Chen, et al.
Blood
|
December 14, 2011
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N Kochenderfer, Mark E Dudley, Steven A Feldman, et al.
JCI Insight
|
December 8, 2017
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
Christopher A Klebanoff, Joseph G Crompton, Anthony J Leonardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2017
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
Yasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, et al.
Blood Cancer Discovery
|
December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Hrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Seminars in Vascular Surgery
|
November 22, 2022
The art of peer review: Guidelines to become a credible and constructive peer reviewer
M Libby Weaver, Rachael Sundland, Alexandra M Adams, et al.
The Oncologist
|
December 21, 2018
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis
Steven M Bair, Lauren E Strelec, Tatyana A Feldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma
Ling Zhang, Richard A Morgan, Joal D Beane, et al.
Page
of 107